Carlyle Group Inc. - 18 Apr 2025 SCHEDULE 13D/A Report for NuCana plc Ordinary Shares, nominal value (pound)0.04 per share (NCNA)

Filing manager: Carlyle Group Inc.
Reporting owner: The Carlyle Group Inc.
Security: NuCana plc Ordinary Shares, nominal value (pound)0.04 per share
Beneficially owned shares: 3,430,062 shares
Large-stake signal: Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Ownership
2.4%
Beneficial ownership of this reported class.
Shares
3,430,062 shares
Shares beneficially owned as disclosed.
Event date
18 Apr 2025
Date tied to the ownership event or amendment.
Accepted by SEC
18 Apr 2025
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 2.4%
Symbol: NCNA
Shares outstanding: 142,919,250 shares
SEC form: SCHEDULE 13D/A
Accepted by SEC: 18 Apr 2025, 18:04:29 UTC
Event date: 18 Apr 2025
Source filing: View source filing

Key filing fact

Carlyle Group Inc. disclosed 2.4% ownership in NuCana plc Ordinary Shares, nominal value (pound)0.04 per share (NCNA) on 18 Apr 2025.

Key facts

Carlyle Group Inc. filed SCHEDULE 13D/A for NuCana plc Ordinary Shares, nominal value (pound)0.04 per share (NCNA).
Disclosed ownership: 2.4%.
Date of event: 18 Apr 2025.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Shared voting power	Signature	Title	CIK
The Carlyle Group Inc.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Chief Financial Officer	0001527166
Carlyle Holdings I GP Inc.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Managing Director and Chief Financial Officer	0001548626
Carlyle Holdings I GP Sub L.L.C.	2.4%	3,430,062	3,430,062	By: Carlyle Holdings I GP Inc., its sole member, /s/ Anne Frederick, attorney-in-fact	John C. Redett, Managing Director and Chief Financial Officer	0001548627
Carlyle Holdings I L.P.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Managing Director	0001548628
CG Subsidiary Holdings L.L.C.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Managing Director	0001790577
TC Group, L.L.C.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Managing Director	0000933790
Carlyle Investment Management L.L.C.	2.4%	3,430,062	3,430,062	/s/ Anne Frederick, attorney-in-fact	John C. Redett, Chief Financial Officer	0001354120
Carlyle Genesis UK LLC	2.4%	3,430,062	3,430,062	By: Carlyle Investment Management L.L.C., its sole member, /s/ Anne Frederick, attorney-in-fact	John C. Redett, Chief Financial Officer	0001941860
Abingworth LLP	2.4%	3,430,062	3,430,062	/s/ John Heard	John Heard, Authorized Signatory	0001397144
Abingworth Bioventures VII LP	2.4%	3,430,062	3,430,062	/s/ John Heard	John Heard, Authorized Signatory	0001688313

CIK / CUSIP context first

Broader feeds